Showing results (1881-1890 of 2,375) with videos related to

Sort By:
Pageof 238
Plos One|August 11, 2018
Cross sectional study of chronic hepatitis B prevalence among healthcare workers in an urban setting, Sierra LeoneThomas A Massaquoi, Rachael M Burke, Guang Yang, et al.
Obstetrics and Gynecology|June 9, 2017
Patterns of Specialty-Based Referral and Perioperative Outcomes for Women With Endometrial Cancer Undergoing HysterectomyJason D Wright, Ling Chen, Lisa Gabor, et al.
Thorax|November 14, 2006
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of diseaseSusan J Davies, John R Gosney, David M Hansell, et al.
Obstetrics and Gynecology|December 2, 2014
Comparative effectiveness of robotically assisted compared with laparoscopic adnexal surgery for benign gynecologic diseaseJason D Wright, Alessandra Kostolias, Cande V Ananth, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 7, 2005
Utility of post-transplant anti-HLA antibody measurements in pediatric cardiac transplant recipientsSteve Xydas, Jane K Yang, Elizabeth M Burke, et al.
Scandinavian Journal of Medicine & Science in Sports|July 11, 2025
How Do Fluctuations in Endogenous Sex Hormones Affect Breast Pain in Female Athletes?Brooke R Brisbine, Jocelyn K Mara, Alannah K A McKay, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 10, 2025
Mind your nose: A randomized controlled trial of olfactory-based memory training for older people with subjective cognitive declineIsabelle J M Burke, Courtney Chesser, Christopher P K Brown, et al.
Diabetes & Metabolism|June 20, 2025
Mitochondrial heteroplasmy-phenotype correlation and response to glucose lowering therapy in subjects with m.3243A>G mutationsN Ng, B Sanchez-Lechuga, C J McCarrick, et al.
Journal of the American Chemical Society|February 13, 2016
A Molten Salt Lithium-Oxygen BatteryVincent Giordani, Dylan Tozier, Hongjin Tan, et al.
Investigational New Drugs|April 18, 2019
A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumorsJeffrey P Sharman, Jennifer J Wheler, Lawrence Einhorn, et al.
Pageof 238